Skip to main content
OpenTrials

Clinical trial condition

Endocrine Gland Neoplasms

Explore clinical trials studying Endocrine Gland Neoplasms. Study availability and eligibility vary by location and protocol.

6,100 public trials 1,371 recruiting studies
Refine in advanced search Browse all conditions

Endocrine Gland Neoplasms trial results

Completed

Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)

NCT02301143

Conditions
Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +5 more
Locations
  • Mayo Clinic - Arizona Scottsdale, Arizona, United States
  • UC Davis Cancer Center Sacramento, California, United States
  • Scripps Clinic Torrey Pines San Diego, California, United States
  • Smilow Cancer Hospital At Yale-New Haven New Haven, Connecticut, United States
View all 42 locations
View Trial Details
Completed

A Study of ABT-263 as Single Agent in Women With Platinum Resistant/Refractory Recurrent Ovarian Cancer

NCT02591095

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • CHU Besançon - Hôpital Jean Minjoz Besançon, France
  • Institut Bergonié Bordeaux, France
  • Centre Francois Baclesse Caen, France
  • Centre Oscar Lambret Lille, France
View all 16 locations
View Trial Details
Completed

EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT01489371

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +22 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • UC Irvine Health/Chao Family Comprehensive Cancer Center Orange, California, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • University of New Mexico Cancer Center Albuquerque, New Mexico, United States
View Trial Details
Completed

Evaluation of TRC105 in the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

NCT01381861

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of California, San Diego La Jolla, California, United States
  • University of Southern California Los Angeles, California, United States
  • Palm Beach Cancer Institute West Palm Beach, Florida, United States
View Trial Details

Related conditions